Dementia drugs linked to weight loss

CHOLINESTERASE inhibitors may cause dangerous weight loss in patients with dementia, a large US study has found.

Over a 12-month period the over-65s who were on these medications were significantly more likely to have lost 4.5kg compared to matched controls.

“This is very relevant to patient care because unintentional weight loss in older adults is associated with many adverse outcomes, including increased rates of institutionalisation and mortality, a decline in functional status and poorer quality of life,” says lead author Dr Meera Sheffrin,